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ABSTRACT 
Serum antibodies to parasite-specific and non-parasite antigens were evaluated using enzyme-linked immunosorbent assay 
(ELISA). Out of the 470 sera collected, 409 were from residents of an onchocerciasis hyper-endemic area, 55 non-endemic 
and 6 European normal sera served as control. The patients’ age, sex, skin microfilaria densities, dermal and ocular clinical 
manifestations (colour of optic disc) have been well characterised. The study population had participated in a placebo-
controlled (n=191) trial of ivermectin (Mectizan®) treatment (n=218). The parasite antigens are phosphate buffered saline 
crude extract of adult worms of Onchocerca volvulus, a recombinant antigen (Ov1.9) and a monoclonal antibody purified 
antigen (Cam 1). The non-parasite antigens are deoxycholate citrate extract of optic nerve (nerve-DOC) and commercially 
available IgA, IgM and IgG were used to assay for rheumatoid factor (Rh-F) auto-antibodies. Generally, antibodies to 
parasite antigens in onchocerciasis patients were remarkably higher than control group (p<0.05) using exact F-test. There 
was no significant difference (p>0.05) in antibodies to nerve-DOC and Rh-F in patients compared to control. Antibodies 
increased with increasing skin snip microfilaria load from 0.69±0.28 with 0mf/mg (n=54) as against 0.80±0.26 for those with 
4-20mf/mg. Observed slight negative correlation in IgG antibody levels and severity of disc colour with mean OD values of 
0.26±0.22 in those graded as having no optic nerve disease (OND) (disc 1, n=86) and 0.17±0.19 for those with severe changes 
(disc 3, n=49) was not statistically significant (P>0.05). An age dependent significant decrease (P<0.05) in antibodies were 
observed with 0.64±0.34 for 15-30yr old (n=48) compared to 0.48±0.35 for those 50yr (n=50) for PBS with a similar trend for 
IgG to Ov1.9 and Cam1. In conclusion, serum parasite-specific and non-parasite antibodies may not be responsible for the 
pathology of optic nerve disease. Onchocerciasis patients were apparently not at higher risk of developing rheumatoid 
arthritis than the control.  
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RESUME 
Les anticorps sériques contre antigènes parasites spécifiques et non parasitaires ont été évalues en utilisant un dosage 
immunoenzymatique (ELISA). Sur les 470 sérums collectés, 409 provenaient de résidents d’une région hyper endémique de 
l’onchocercose, 55 sérums normaux non endermiques et 6 européens ont servi de témoins. L’âge des patients, le sexe, les 
densités de microfilaires, cutanées, les manifestations cutanées et oculaires (couleur du disque optique) ont été bien 
caractérisées. La population étudiée avait participé à un essai contrôlé par placebo (n=191)sur le traitement à l’ivermectine 
(Mectizan®) (n=218). Les antigènes parasites sont phosphate tamponné saline extrait brut de vers adultes de l’Onchocerca 
volvulus, un antigène recombinant (Ov1.9) et un antigène purifié par un anticorps monoclonal (Cam 1).  Les antigènes non 
parasitaire sont l’extrait de citrate de desoxycholate du nerf optique(nerf - DOC) et on a utilisé des IgA, IgM et IgG 
disponibles dans le commerce pour doser les auto anticorps du facteur rhumatoïde (Rh – F). Généralement, les anticorps 
contre les antigènes parasitaires chez les patients atteints d’onchocercose étaient remarquablement plus élevés que le 
groupe témoin (p>0,05) en utilisant le test F – exact. Il n’y avait pas de différence significative entre les anticorps au nerf – 
DOC et les facteurs rhumatoïdes (Rh - F) chez les patients par rapport au témoin. Les anticorps augmentaient avec 
augmentation de la charge microfilaire de coupe de peau de 0,69±0,28 avec 0mf/mg (n=54) contre 0,80±0,26 pour ceux avec 4-
20mf/mg. On a observé une légère corrélation négative dans les taux d’anticorps IgG et la gravité de la couleur du disque 
avec des valeursmoyennes de OD de 0,26±0,22 chez celles classées comme n’ayant pas de maladie du nerf optique (OND) 
(disque 1, n=86) et 0,17±0,19 pour les personnes ayant des changements sévères (disque 3, n=49) n’était pas statistiquement 
significative (P>0,05). Une diminution significative de de l’âge (P<0,05) dans les extraits d’anticorps a été observée avec 




conclusion, les parasites spécifiques du sérum et  les anticorps non parasitaires ne peuvent pas être responsable pour la 
pathologie de la maladie du nerf optique.  Les patients atteints d’onchocercose n’avaient apparemment pas un risque plus 
élevé de développer la polyarthrite rhumatoïde que le témoin. 
Mots clés: L’onchocercose; Les anticorps; les antigènes; Réponses immunitaires; L’vermectine. 
 
INTRODUCTION                                                       
Current control of onchocerciasis has relied on the 
mass drug administration of Ivermectin or 
Mectizan® (1). Lately, more emphasis is placed on 
operational research, drug screening and 
diagnostics development, while less attention is 
focused on basic research on the disease. Study into 
the immune responses of any infection is for a 
better understanding of the basis or mechanism of 
immunopathology including the role of 
autoimmune involvement, the diagnostic 
usefulness and to identify potential vaccine 
candidate immunogens. In onchocerciasis, humoral 
and cellular immune reactivity to parasite or the 
substance they release after death varies from one 
individual to another, and also show diverse 
clinical manifestations (2, 3). With time, the larva 
forms (microfilariae) and adult worm (macrofilaria) 
aged and die (4).  Their fragments elicit host 
inflammatory responses with bystander effects 
believed to underlie dermal and ocular changes (5, 
6). Immunological mechanisms are believed to play 
a major role in the broad range of dermal and 
ocular pathologies complicating Onchocerca volvulus 
infections. These have therefore prompted 
questions concerning involvement of antibodies to 
parasites-specific and autoantigens in the 
pathogenesis of onchocerciasis.  
The parasite materials share a lot of biochemical 
and immunological homology with other parasites, 
related and unrelated species which are often co-
endemic with onchocerciasis. This has posed a 
major problem in interpreting results of assays 
using undefined crude antigens, thus making the 
identification of diagnostic and clinical trends very 
difficult. The measure of antibody class and 
subclass response is thought would be able to 
reveal host-parasite immunological interactions that 
are involved in pathogenesis, and restricted to 
discrete clinical entity (7). Thus far, a positive 
association between skin microfilariae load and 
IgG3 to low molecular weight adult Onchocerca 
volvulus antigens and changes in immune responses 
following treatment have been reported while a 
possible cross-reactivity of parasite with host eye 
tissue component has been suggested. In this 
investigation, a measure of serum antibody against 
parasite crude and recombinant, and non-parasite 
rheumatoid factor (Rh-F) antigens using enzyme-
linked immunosorbent assay (ELISA) were 
performed to know if there is any clinical trend 
based on age, sex, mf load and eye pathology 
(change in optic nerve disc colour). ELISA has been 
reported to show greater sensitivity and measuring 
IgG RF and IgA in addition to IgM RF by (8). 
Onchocerciasis was listed by (9) to be amongst 
diseases with possible features of autoantibodies to 
RA. Although there are formal classification criteria 
for RA according to the American College of 
Rheumatology, RFs are not a specific diagnostic 
tool for RA. However, the presence of high RF titers 
is predictive for developing RA in non-
symptomatic subjects and titers are associated with 
a more aggressive and destructive course and with 
the occurrence of extra-articular manifestations in 
RA patients. Possible involvement of autoimmunity 
in the pathology of the skin and ocular lesions have 
been suspected. It has been suggested that 
autoimmunological reactions resulting from cross-
reactivity between parasite antigens and 
components of eye tissues contribute to 
development of ocular pathology (10). Assessing 
the levels of antibodies in groups of clinical and 
parasitological defined onchocerciasis patients 
compared to control will show the cause and effect 
relation.  
The aim of this research study is to determine the 
involvement of parasite-specific and non-parasite 
auto-antigens in the immunopathology of optic 
nerve disease, which is one of the major causes of 
irreversible blindness, skin clinical manifestations 
and correlation with status of microfilardermia. 
Secondly, the study will also determine the likely 
risk of developing rheumatoid arthritis in 
onchocerciasis patients compared to control.  
MATERIALS AND METHODS 
Experimental Design: A total of 470 sera, 
comparison 409 from onchocerciasis patients, 55 
from Fatika, a non-endemic area in Kaduna State, 
Nigeria and 6 European normals as controls were 
screened for antibody responses to parasite and 
non-parasite antigens. The onchocerciasis patients 
comprised of 218 individuals receiving ivermectin 
and 191 receiving placebo. The individuals were 
previously characterized by age, sex, skin mf 
density and ocular pathology (colour of optic disc). 
All sera samples were stored at -70oC in deep-
freezer in 30µl aliquot and thawed once before use. 
Antigens: Adult O. volvulus, phosphate buffered 
saline (PBS)-extracted crude antigen, and a 
monoclonal antibody purified antigen designated 
Cam 1 were prepared and provided by Dr. 
Engelbrecht. The Ov1.9 recombinant antigen 
described by (11) was supplied to the Immunology 
Research Laboratory (I.R.L), NITR, Kaduna, by Dr. 
McKennie of Cambridge University. A deoxy 




(nerve-DOC) was kindly provided by the Institute of Ophthalmology, Cambridge University. Dr. 
McKennie. for Rh-F assay, commercially available 
human IgA, IgG and IgM (Calbiochem, U.K.) were 
used as auto-antigens as described by (8). The PBS 
extract was used at 1:1000 except for IgA at 1:500.  
ELISA Protocol: Assays were performed following 
the protocol of Engelbrecht et al. (1992) with slight 
modification at the NITR Immunology Research 
laboratory. Wells of microtitre plates were coated 
with antigens and stored overnight in the fridge at 
4ºC. Microplates were washed 3-5 times between 
each step. All other steps were performed at room 
temperature ranging from 28-32ºC. Sera, antigens, 
anti-human IgG and anti-mouse horseradish 
peroxidase conjugates were subjected to pre-
titration experiment in checkerboard to obtain the 
optimal working concentration or dilution. Sera 
were used at 1:400 for IgG and IgG4, 1:250 for IgG1 
and IgG3, and 1:50 for IgA. The PBS extract was 
used at 1:1000 for IgG, 1:2000 for IgG1, 1:8000 for 
IgG3 and IgG4 and 1:500 for IgA. Anti-mouse IgG 
hydrogen peroxidase was used at 1:800. The 
binding of antigen to antibody was demonstrated 
with hydrogen peroxide (H202) in disodium 
hydrogen phosphate (Na2HPO4), citric acid and 
freshly prepared orthophenylene diamine (OPD) 
substrate solution at 15µl per well allowed to react 
for 15 minutes. The enzyme reaction was 
terminated with 2M H2SO4 at 30µl per well and 
plates were read after 5 minutes in a Dynatech 
MR4000 ELISA reader. 
Data Analysis: The mean optical density (OD) 
values of cases and control, treated and non-treated, 
male or female, stratification by skin MFL and 
subjective grading of optic disc colour were 
computed using Microsoft Excel spreadsheet. 
Differences in mean±standard deviation (stdev) 
were subjected to exact F-test of unpaired data at 
0.05 level of error.  
RESULTS                                                                                                                                                                                       
Optical density (OD) values of the ELISA tests at 
492nm of serum antibodies reaction with the 
parasite and non-parasite antigens were analysed. 
The mean and standard deviation of the OD-values 
were computed for each group and sub-groups. 
Antibody responses (IgA, IgG, IgG1, IgG3, and IgG4) 
to PBS-crude extract, Ov1.9 and Cam 1 antigens in 
onchocerciasis patients were remarkably higher 
than those of control group (Table 1). Onchocercal 
sera (n=409) gave higher total anti-IgG titres of 
0.75±0.24 compared to 0.62±0.3 and 0.37±0.18 for 
Ov1.9 and Cam 1, respectively. These values were 
comparatively higher than the mean values 
obtained for Fatika and European controls shown 
on Table 1. Similar trends were observed for the 
isotype (IgG1, IgG3 and IgG4) antibodies to the 
three antigens (PBS-extract, Cam1 and Ov1.9). The 
differences between the IgG4 responses to PBS-
extract and Cam1 antigens were statistically 
significant (p<0.05). With cut-off points set as mean 
± 3stdev of European control for PBS-extract (0.05) 
and Cam1 antigens (0.06) showed that 375 (91.7%) 
and 361 (88.3%) were found to be serological 
positive, respectively. Mean OD values for male 
were slightly higher than female (p>05). Only slight 
difference in anti-Rh-F IgG of 0.64±0.16, 0.59±0.15 
and 0.41±0.22 for onchocerciasis sera, non-endemic 
and European controls, respectively were recorded. 
Therefore, there was no further analysis of the data 
on the basis of bioclinical and parasitological 
variables.   
In isotype assays, anti IgG4 titres were prominently 
elevated in patients with a mean of 0.58±0.33 while 
absent in controls. IgG1 antibody titres were 
slightly high in patients with mean±stdev 0.24±0.23 
compared with 0.11±0.15 OD-value for Fatika non-
endemic control. European normals (n=6) were 
however negative. IgG3 assay was virtually 
negative irrespective of the test sample. Anti IgA 
titres were slightly higher in patients with a mean 
of 0.24±0.17 than controls, 0.19±0.14 for Fatika and 
0.0.13±0.07 for European normals. Anti IgG2, IgE 
and IgM could not be developed due to high 
background reactions. Similar trend in antibody 
responses to PBS-extract were observed for Ov1.9 
antigens, except that total IgG titres were 
comparatively lower- about half the OD-value 
(0.37±0. 2) as against 0.62±0.3. Overall, there were 
no significant differences between treated and non-





TABLE 1: ANTIBODY RESPONSES TO PARASITE ANTIGENS COMPARED TO CONTROLS 
(i) Antigen-Antibody     Reaction PBS IgG PBS IgG1 PBS IgG3 IgG4 PBS IgA  
Onchocerciasis sera (n=409) 0.75±0.24§ 0.24±0.23 0.09±0.14 0.58±0.33φ 0.24±0.17 
Non-endemic control (n=55) 0.38±0.26§ 0.11±0.15 0.01±0.05 0.08±0.22φ 0.19±0.14 
European negative (n=6) 0.11±0.05§ 0.01±0.01 0.01±0.01 0.02±0.01φ 0.13±0.07 
(ii)  Antigen-Antibody  Reaction Ov1.9 IgG Ov1.9 IgG1 Ov1.9 IgG3 Ov1.9 IgG4 Ov1.9 IgA 
 
Onchocerciasis sera (n=409) 0.62±0.3ø 0.16±0.15 0.08±0.06 0.38±0.34¤ ND 
Non-endemic control (n=55) 0.37±0.2ø 0.1±0.06 0.05±0.02 0.11±0.19¤ ND 
European negative (n=6) 0.26±0.11ø 0.06±0.01 0.03±0.01 0.06±0.08¤ ND 
(iii) Antigen-Antibody Reaction Cam 1 IgG Cam1 IgG1 Cam 1 IgG3 Cam 1 IgG4 IgA 
Onchocerciasis sera (n=409) 0.37±0.18α 0.30±0.19 0.11±0.15 0.44±0.33ẞ ND 
Non-endemic control (n=55) 0.23±0.15 α 0.19±0.16 0.08±0.08 0.05±0.19 ẞ ND 
European negative (n=6) 0.15±0.07 α 0.06±0.03 0.05±.04 0.00±0.02 ẞ ND 
The §, φ, ø, ¤, α, and ẞ signs showed differences between onchocerciasis and non-endemic control were statistically significant 
(p<0.05) by exact F-test. 
The OD values of non-treated group increases with 
increase in MFL for IgG anti-PBS-extract with 
mean±stdev of 0.69±0.28 for 0mf/mg (n=54) vs 
0.8±0.26 for 4-20mf/mg (n=52). IgG4 had 
corresponding values of 0.45±0.32 vs 0.66±0.34. A 
similar trend was observed in the treated group, 
where IgG1 values were 0.19±0.23 (n=47) vs 
0.32±0.20 (n=46) for the untreated group as shown 
on Table 2. Except for IgG response to 0vl.9 in 
treated group with 0.56±0.31 vs 0.7±0.3, there was 
no appreciable change with increase in mf density. 
Figure 2 shows there is age dependency with 
significant decrease (P<0.05) in mean OD values for 
IgG4 against PBS-extract from 0.64±0.34 for 15-30yr 
old (n=48) compared to 0.48±0.35 for those 50yr 
(n=50). Similarly, IgG4 reactivity to 0v1.9 were 
0.47±0.37 vs 0.31±0.32 were comparably not 
different from those of Cam 1.
  
                  
FIGURE 1: ANTIBODY RESPONSES TO MACROFILARIA LOAD IN TREATED AND NON-TREAT SUBGROUPS. 
ELSA=ENZYME LINKED IMMUNOSORBENT ASSAY, IG= IMMUNOGLOBULIN, MF= MICROFILARIA, NM-NANOMETRE, 





    
FIGURE 2: ANALYSIS OF ANTIGEN AND ANTIBODY REACTION IN TREATED ONCHOCERCIASIS PATIENTS BY AGE 
 
In the treated group, a slight negative correlation in 
IgG antibody levels and severity of disc colour with 
mean OD values of 0.26±0.22 in those graded as 
having no OND (disc 1, n=86) and 0.17±0.19 for 
those with severe changes (disc 3, n=49). There was 
no significant difference (p>0.05) between cases and 
control for antibody response to optic nerve-DOC 
extract (only IgG and IgG4 were evaluated) neither 
between treated nor untreated groups in antibody 
levels. 
DISCUSSION                                                                    
Involvement of the parasite and non-parasite 
specific antibody responses in onchocerciasis has 
been studied. Active humoral immune response 
elicited by the antigenic stimulation of dead 
microfilariae has been demonstrated in this study. 
High level antibody responses against parasite 
antigens were more in onchocerciasis patients than 
in control, and the prominence of IgG than IgA is 
widely documented. The significant result obtained 
from the overall assay is observed preferential 
elevation of anti IgG4 titres in patients’ sera. This 
finding is in agreement with those reported by (3, 
12, 13, 14) Most of the IgG were accounted for by 
IgG4 subclass followed by IgG1 and IgG3. Similar 
findings were reported in children by (15).  
Changes in parasite specific IgE and IgG antibody 
responses were transiently enhanced at post- 
diethylcarbamzine (DEC) or Banocide® treatment, 
and after treatment, parasites possibly release 
antigens previously hidden from host immune 
response (16). On the contrary, there was no change 
in antibodies after ivermectin treatment is a 
confirmation that the difference may explain 
possible development of Mazzotti reaction peculiar 
to DEC treatment, which is very minimal or absent 
in ivermectin treatment.    
It is very likely that the predominant subclass IgG4 
may act in blocking hypersensitivity reaction. The 
clinical status, age and mf density dependency of 
antibody responses have been documented by other 
investigators. Expectedly, reactivity to PBS-extract 
was more than those of Ov1.9 and Cam 1 antigens, 
since the formal contains immuno-dominant 
antigens (13, 17). This may be due to the presence of 
many epitopes, such as, phosphoryl choline (PC) 
and other carbohydrate determinants in crude PBS 
extract. The sensitivity and specificity of IgG4 
against PBS-extract was higher than those of Ov1.9, 
which is an indication that the later stimulates less 
antibody response (11). Measuring IgG4 response to 
PBS extract hitherto has been documented to have 
potential diagnostic value (15). This subclass is non-
reactive to phosphoryl-choline (PC), an 
immunodominant molecule responsible for the 
majority of cross-reactivity. Although an increase in 
both IgG and IgM reactivity with Rh-F has been 
established in loiasis patients with or without 
glomerulonephritis, the observed slight differences 
between onchocerciasis cases and controls, deserves 
further studies to validate if they play a protective 
role or are just epiphenomena.  Onchocerciasis has 
been listed among the diseases with high risk of 
detecting Rh-factor by (18). Results obtained from 
this study did not support the rheumatoid arthritis 
playing any role in autoimmune disease involving 
any of the antibody classes (IgA, IgG and IgM). This 
is in accordance with the held belief that raised 
levels of IgM, IgG, and IgA RF have been reported 
in patients with Rheumatoid Arthritis (19). Several 
groups have reported that a high level of IgA RF is 
prognostic for a more severe disease outcome (20 
and 21). 
From all indication, it is obvious that the varied 
clinical manifestations of onchocerciasis are not due 
to direct parasite attrition (22). Moreover, it has 
been established that dead microfilaria elicit 
bystander response that attract cellular immune 
mechanism involving cyto-adherence in the process 
of clearing dead microfilariae with consequence 
dermal and ocular tissue damage have been 
documented by (6, 23). It has been shown by (24) 
that both IgM- and IgG-containing complexes were 




between the levels of complexes containing these 
isotypes. One of the cardinal manifestations of 
autoimmune disorders is the presence of auto-
antibodies and/or self-reacting cells (25), however, 
the detection of these autoimmune activities are not 
necessarily associated with clinical findings. 
High level antibody responses against parasites 
antigens showed that IgG was more prominent 
than IgA. Most of the IgG were accounted for by 
IgG4 subclass followed by IgG1 and IgG3. This is a 
possible indication of the predominant subclass 
IgG4 may act in blocking hypersensitivity reaction 
(12). The clinical status, age, and mf density 
dependency of antibody responses have been 
documented by other investigators (11, 15). 
Expectedly, sensitivity and specificity of IgG4 
against PBS-extract is higher than those of Ov1.9 
and Cam 1, which is an indication that they 
stimulate less antibody responses. Measuring of 
IgG4 to PBS-extract has been reported to have 
potential diagnostic value. 
Although an increase in both IgG and IgM Rh-F has 
been established in loiasis patients with or without 
glomerulonephritis, the observed slight differences 
between onchocerciasis cases and controls, deserve 
further studies to validate if they play a role 
protective role or not.  More importantly, the study 
was carried out in savannah onchocerciasis 
endemic area, which may differ from what obtains 
with the forest species of the parasite.  
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